Repurposing Pentacyclic Triterpenoids as Ferroptosis Inducing Agents for Cancer Therapies
Current Pharmacology Reports · 20.04.2026 · 12 (1)
DOI: 10.1007/s40495-026-00453-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Pharmacology Reports, online erschienen am 20.04.2026. Verfasst von Siqi Li und 8 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben. Gefördert von: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union M…, National Natural Science Foundation of China, Li Ka-Shing Foundation at Shantou University Medical College.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union M…
- National Natural Science Foundation of China
- Li Ka-Shing Foundation at Shantou University Medical College
- Li Ka-Shing Foundation STU-GTIIT Joint-research Grant
Zitieren
APA
Li, S., He, J., Zhou, Z., Luo, Y., Zhuang, J., Tanziela, T., Gao, L., Tao, W., & Wong, N. (2026). Repurposing Pentacyclic Triterpenoids as Ferroptosis Inducing Agents for Cancer Therapies. Current Pharmacology Reports, 12(1). https://doi.org/10.1007/s40495-026-00453-2
Vancouver
Li S, He J, Zhou Z, Luo Y, Zhuang J, Tanziela T, et al. Repurposing Pentacyclic Triterpenoids as Ferroptosis Inducing Agents for Cancer Therapies. Current Pharmacology Reports. 2026;12(1). doi:10.1007/s40495-026-00453-2
BibTeX
@article{Li2026,
author = {Li, Siqi and He, Jun-Xian and Zhou, Ziyuan and Luo, Yi-Hui and Zhuang, Jiale and Tanziela, Tanziela and Gao, Lei and Tao, Wensi and Wong, Nai-Kei},
title = {Repurposing Pentacyclic Triterpenoids as Ferroptosis Inducing Agents for Cancer Therapies},
journal = {Current Pharmacology Reports},
year = {2026},
volume = {12},
number = {1},
doi = {10.1007/s40495-026-00453-2}
}
EUVIMED